On May 17, 2024, XORTX Therapeutics Inc. submitted a Form 6-K to report its filing under the Securities Exchange Act of 1934. This is a routine documentation for foreign private issuers and does not indicate any significant events or changes.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.